Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
labcentral
2
×
life sciences
20/20 healthcare partners
amgen ventures
amyotrophic lateral sclerosis
anthony despasqua
bioinnovation capital
biolabs
boston top stories
chemotherapy
christian angermayer
daraprim
dolby family ventures
drug pricing
drugs
enclear therapies
epipen
epipens
exome
financing
funding
gene therapy
generic drugs
gf securities
global health sciences fund
hillel bachrach
insulin
jason camm
johannes fruehauf
karimah es sabar
life science
martin shkreli
medical device
mylan
national blog main
national xcon
novartis
What
associated
biotech
companies
develop
device
dialysis
disease
diseases
driving
drug
drugs
enclear
good
harmful
healthcare
history
improved
industry
innovation
innovations
investment
life
long
medical
nets
neuro
neurodegenerative
new
outcomes
pricing
proteins
proud
public
raised
sciences
target
test
therapies
wide
working
Language
unset
2
×
Current search:
labcentral
×
unset
×
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
